Daniel Camardo
Director/Board Member bei CommunityHealth NFP
Vermögen: 1 712 $ am 31.03.2024
Profil
Daniel A.
Camardo is currently the Director at CommunityHealth NFP.
Previously, he held positions as the CEO, CFO, Secretary, Director & CAO at Athersys, Inc. in 2022, Senior Director-US Commercial Operations at Astellas Pharma US, Inc. in 2003-2004, Vice President-Sales & Operations at Clarus Therapeutics, Inc. in 2014-2015, and President-US & Executive Vice President at Horizon Therapeutics Plc in 2015-2022.
He obtained his undergraduate degree from Rochester Christian University and an MBA from Kellogg School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ATHERSYS, INC.
0,46% | 04.10.2023 | 285 341 ( 0,46% ) | 1 712 $ | 31.03.2024 |
Aktive Positionen von Daniel Camardo
| Unternehmen | Position | Beginn |
|---|---|---|
| CommunityHealth NFP | Director/Board Member | - |
Ehemalige bekannte Positionen von Daniel Camardo
| Unternehmen | Position | Ende |
|---|---|---|
| ATHERSYS, INC. | Chief Executive Officer | 31.12.2023 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | 01.02.2022 |
Clarus Therapeutics, Inc.
 Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | Sales & Marketing | 01.09.2015 |
Astellas Pharma US, Inc.
 Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Corporate Officer/Principal | 01.01.2004 |
Ausbildung von Daniel Camardo
| Rochester Christian University | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ATHERSYS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Clarus Therapeutics, Inc.
Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | Health Technology |
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Health Technology |
| CommunityHealth NFP |
